Transcode Therapeutics annual capital expenditures (capex)
2021
2022
2023
2024
2025
Transcode Therapeutics Capital Expenditures (CapEx) Growth & History (RNAZ)
Transcode Therapeutics's capital expenditures (capex) was $6,660 for fiscal 2025.
View full Transcode Therapeutics company overviewTranscode Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6,660 | −$15,101 | −69.39% |
| 2024 | 2024-12-31 | $21,761 | −$13,848 | −38.89% |
| 2023 | 2023-12-31 | $35,609 | −$65,310 | −64.72% |
| 2022 | 2022-12-31 | $100,919 | −$153,901 | −60.40% |
| 2021 | 2021-12-31 | $254,820 | — | — |
Transcode Therapeutics quarterly capital expenditures (capex)
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $500 | $500 | — |
| Q3 2024 | 2024-09-30 | $12,870 | $8,264 | +179.42% |
| Q2 2024 | 2024-06-30 | $4,555 | −$13,552 | −74.84% |
| Q1 2024 | 2024-03-31 | $3,836 | −$9,060 | −70.25% |
| Q4 2023 | 2023-12-31 | $0 | −$28,215 | — |
| Q3 2023 | 2023-09-30 | $4,606 | $4,606 | — |
| Q2 2023 | 2023-06-30 | $18,107 | −$23,940 | −56.94% |
| Q1 2023 | 2023-03-31 | $12,896 | −$17,761 | −57.93% |
| Q4 2022 | 2022-12-31 | $28,215 | −$57,513 | −67.09% |
| Q3 2022 | 2022-09-30 | $0 | −$71,551 | — |
| Q2 2022 | 2022-06-30 | $42,047 | $19,807 | +89.06% |
| Q1 2022 | 2022-03-31 | $30,657 | −$44,644 | −59.29% |
| Q4 2021 | 2021-12-31 | $85,728 | — | — |
| Q3 2021 | 2021-09-30 | $71,551 | — | — |
| Q2 2021 | 2021-06-30 | $22,240 | — | — |
| Q1 2021 | 2021-03-31 | $75,301 | — | — |
Transcode Therapeutics capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Transcode Therapeutics's capital expenditures (capex) decreased from $254,820 to $6,660, a change of −$248,160. The latest reported quarter, Q4 2024, shows $500.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Transcode Therapeutics source filings ↗